346 related articles for article (PubMed ID: 29186899)
1. Obstacles to Brain Tumor Therapy: Key ABC Transporters.
Wijaya J; Fukuda Y; Schuetz JD
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186899
[TBL] [Abstract][Full Text] [Related]
2. ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model.
Mittapalli RK; Chung AH; Parrish KE; Crabtree D; Halvorson KG; Hu G; Elmquist WF; Becher OJ
Mol Cancer Ther; 2016 May; 15(5):819-29. PubMed ID: 26883271
[TBL] [Abstract][Full Text] [Related]
3. Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.
Bakhsheshian J; Wei BR; Chang KE; Shukla S; Ambudkar SV; Simpson RM; Gottesman MM; Hall MD
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20801-6. PubMed ID: 24297888
[TBL] [Abstract][Full Text] [Related]
4. ATP-binding cassette transporters restrict drug delivery and efficacy against brain tumors even when blood-brain barrier integrity is lost.
de Gooijer MC; Kemper EM; Buil LCM; Çitirikkaya CH; Buckle T; Beijnen JH; van Tellingen O
Cell Rep Med; 2021 Jan; 2(1):100184. PubMed ID: 33521698
[TBL] [Abstract][Full Text] [Related]
5. Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation.
Lemmen J; Tozakidis IE; Bele P; Galla HJ
Brain Res; 2013 Mar; 1501():68-80. PubMed ID: 23340159
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas.
Carcaboso AM; Elmeliegy MA; Shen J; Juel SJ; Zhang ZM; Calabrese C; Tracey L; Waters CM; Stewart CF
Cancer Res; 2010 Jun; 70(11):4499-508. PubMed ID: 20460504
[TBL] [Abstract][Full Text] [Related]
7. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
[TBL] [Abstract][Full Text] [Related]
8. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier.
Dauchy S; Dutheil F; Weaver RJ; Chassoux F; Daumas-Duport C; Couraud PO; Scherrmann JM; De Waziers I; Declèves X
J Neurochem; 2008 Dec; 107(6):1518-28. PubMed ID: 19094056
[TBL] [Abstract][Full Text] [Related]
9. The expression and functional characterization of ABCG2 in brain endothelial cells and vessels.
Zhang W; Mojsilovic-Petrovic J; Andrade MF; Zhang H; Ball M; Stanimirovic DB
FASEB J; 2003 Nov; 17(14):2085-7. PubMed ID: 12958161
[TBL] [Abstract][Full Text] [Related]
10. Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug efflux.
Lin F; de Gooijer MC; Hanekamp D; Brandsma D; Beijnen JH; van Tellingen O
CNS Oncol; 2013 May; 2(3):271-88. PubMed ID: 25054467
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up.
Agarwal S; Hartz AM; Elmquist WF; Bauer B
Curr Pharm Des; 2011; 17(26):2793-802. PubMed ID: 21827403
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of multidrug resistance transporters at the blood-brain barriers.
Scherrmann JM
Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):233-46. PubMed ID: 16922639
[TBL] [Abstract][Full Text] [Related]
13. Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro.
von Wedel-Parlow M; Wölte P; Galla HJ
J Neurochem; 2009 Oct; 111(1):111-8. PubMed ID: 19656257
[TBL] [Abstract][Full Text] [Related]
14. Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat.
Ek CJ; Wong A; Liddelow SA; Johansson PA; Dziegielewska KM; Saunders NR
Toxicol Lett; 2010 Aug; 197(1):51-9. PubMed ID: 20466047
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a side population of astrocytoma cells in response to temozolomide.
Chua C; Zaiden N; Chong KH; See SJ; Wong MC; Ang BT; Tang C
J Neurosurg; 2008 Nov; 109(5):856-66. PubMed ID: 18976075
[TBL] [Abstract][Full Text] [Related]
16. ABC transporters and the blood-brain barrier.
Begley DJ
Curr Pharm Des; 2004; 10(12):1295-312. PubMed ID: 15134482
[TBL] [Abstract][Full Text] [Related]
17. Signaling pathways that regulate basal ABC transporter activity at the blood- brain barrier.
Miller DS; Cannon RE
Curr Pharm Des; 2014; 20(10):1463-71. PubMed ID: 23789954
[TBL] [Abstract][Full Text] [Related]
18. Apical ABC transporters and cancer chemotherapeutic drug disposition.
Durmus S; Hendrikx JJ; Schinkel AH
Adv Cancer Res; 2015; 125():1-41. PubMed ID: 25640265
[TBL] [Abstract][Full Text] [Related]
19. Role of ABC transporters in the chemoresistance of human gliomas.
Declèves X; Amiel A; Delattre JY; Scherrmann JM
Curr Cancer Drug Targets; 2006 Aug; 6(5):433-45. PubMed ID: 16918310
[TBL] [Abstract][Full Text] [Related]
20. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
